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Retrieval represents a dynamic process that may require neuro-
modulatory signaling. Here, we report that the integrity of the
brain histaminergic system is necessary for retrieval of inhibitory
avoidance (IA) memory, because rats depleted of histamine
through lateral ventricle injections of α-fluoromethylhistidine
(a-FMHis), a suicide inhibitor of histidine decarboxylase, displayed
impaired IA memory when tested 2 d after training. a-FMHis was
administered 24 h after training, when IA memory trace was al-
ready formed. Infusion of histamine in hippocampal CA1 of brain
histamine-depleted rats (hence, amnesic) 10 min before the reten-
tion test restored IA memory but was ineffective when given in
the basolateral amygdala (BLA) or the ventral medial prefrontal
cortex (vmPFC). Intra-CA1 injections of selective H1 and H2 receptor
agonists showed that histamine exerted its effect by activating the
H1 receptor. Noteworthy, the H1 receptor antagonist pyrilamine
disrupted IA memory retrieval in rats, thus strongly supporting
an active involvement of endogenous histamine; 90 min after
the retention test, c-Fos–positive neurons were significantly fewer
in the CA1s of a-FMHis–treated rats that displayed amnesia com-
pared with in the control group. We also found reduced levels of
phosphorylated cAMP-responsive element binding protein (pCREB)
in the CA1s of a-FMHis–treated animals compared with in controls.
Increases in pCREB levels are associated with retrieval of associated
memories. Targeting the histaminergic system may modify the re-
trieval of emotional memory; hence, histaminergic ligands might re-
duce dysfunctional aversive memories and improve the efficacy of
exposure psychotherapies.
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Memory determines the uniqueness of our personal historyand is decisive for each individual to survive and prosper.
It is a multistate process that includes acquisition, consolidation,
and retrieval (1). Whereas considerable advancement has been
made toward understanding the specific brain structures (e.g.,
amygdala, prefrontal cortex, and hippocampus) and molecular
mechanisms (receptors and signaling pathways) that underlie
acquisition and consolidation (2, 3), the understanding of re-
trieval has lagged behind, although it is ultimately the only
possible measure of memory (4–6). Indeed, retrieval is not
simply a static readout of stored information; rather, it repre-
sents a dynamic process that can be studied separately from ei-
ther acquisition or consolidation, with which it shares similar
mechanisms (1, 7, 8). Furthermore, retrieval can elicit specific
processes that modify the recalled memory (9). In this regard,
protein synthesis, a necessary step in the transfer of a labile
short-term memory into a stable long-term memory (LTM) (2),
is required to enable retrieval, because infusion of protein syn-
thesis inhibitors in the amygdala 10 min before retrieval im-
paired fear memory expression (10). An interesting question is
whether neuromodulatory signaling is required for not only
memory acquisition and consolidation (11) but also, retrieval.
There is evidence that adrenergic signaling is required for the
retrieval of various types of hippocampus-dependent memory in
mice (12) as well as in humans (13). Intrahippocampal blockade
of metabotropic glutamate or alpha-amino-3-hydroxyl-5-methyl-
4-isoxazolepropionic acid (AMPA) receptors immediately before
retrieval impaired LTM expression of an inhibitory avoidance
(IA) response (7), thus suggesting that glutamatergic signaling in
hippocampus is necessary for retrieval of an aversive memory. In
contrast, cholinergic and dopaminergic signaling contributes to
acquisition and/or consolidation but is generally not required for
retrieval (6). The histaminergic system modulates memory con-
solidation in many cognitive tasks from IA to fear conditioning
and object recognition (14–16). We recently showed that rats
were able to consolidate an IA memory only when the brain
histaminergic system was intact (17). Histamine within the brain
is synthesized from histidine by histidine-decarboxylase solely in
hypothalamic tuberomamillary nucleus neurons (18), which are
organized into functionally distinct circuits (19), display selective
control mechanisms (19, 20), and impinge on different brain
regions, including amygdala, prefrontal cortex, and hippocam-
pus, that are responsible for many forms of learning (21).
Based on the above findings, it is conceivable that histaminergic
signaling is required for memory retrieval as well. Consequently, this
study was specifically designed to address this question using an IA
task, an associative learning paradigm that has largely contributed
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to the understanding of memory processes (22). We first examined
whether brain histamine depletion through administration of the
histidine-decarboxylase suicide inhibitor α-fluoromethylhistidine
(a-FMHis) (23) in the lateral ventricle (LV) 24 h after training
affected IA retrieval. Then, we tested whether the local infusion of
histamine in the basolateral amygdala (BLA), the ventral medial
prefrontal cortex (vmPFC), or the CA1 region of the dorsal hippo-
campus overcame a-FMHis–elicited impairment of retrieval, and
we characterized the type of histamine receptor involved. We also
investigated changes in neuronal activity by assessing after retrieval
the pattern of c-Fos expression as well as cyclic adenosine mono-
phosphate (cAMP)-responsive element binding protein (CREB)
phosphorylation in BLA, vmPFC, and CA1 region of histamine-
depleted rats. Finally, we investigated the ability of histamine to
restore retrieval after administration of protein synthesis inhibition
in the CA1 region.
Results
Depletion of Histamine Impairs Retrieval Independently of Consolidation.
We recently showed that intra-LV infusion of a-FMHis (5 μg/μL)
quickly and fully suppressed the release of brain histamine mea-
sured by microdialysis, which was restored to control levels after
about 48 h (17). Thus, to investigate the role of endogenous his-
tamine in retrieval, we examined the performance of rats infused
into the LV with a-FMHis 24 h after the IA training session. The
retention test was carried out 48 h after training. Latencies were
compared with those of rats treated with a-FMHis 24 h before
training and animals given equivalent infusions of saline (controls).
Latencies of all groups during IA training did not differ. Fig. 1
shows the stepdown latency during testing of rats treated with
a-FMHis and control. One-way ANOVA performed at the re-
tention test revealed a significant difference across groups (F2,41 =
62.89; P < 0.0001). Additional analysis with Bonferroni’s multiple
comparisons tests (MCT) showed that latencies of all rats treated
with a-FMHis either 24 h before or 24 h after IA training were
significantly shorter than those of controls. Further analysis with
Bonferroni’s MCT showed that latencies of all rats treated with
a-FMHis, either 24 h before or after IA training, were significantly
shorter than those of controls. As a-FMHis effect on histamine
synthesis persists for about 48 h (22), it is conceivable that rats re-
ceiving a-FMHis prior to IA training lacked integrity of the hista-
minergic system during the consolidation process, whereas those
treated 24 h after training, during the retrieval. These findings confirm
that histamine depletion impairs the consolidation of IAmemory (17)
and suggest that it also worsens IA-LTM expression by influences on
memory retrieval mechanisms. To further test these hypotheses, we
investigated whether intracerebral administration of histamine re-
versed the amnesic effect of histamine depletion caused by a-FMHis.
Effects of Histamine Infusion into the BLA, vmPFC, or CA1 on a-FMHis–
Induced Amnesia.Histamine (1 μg/μL) was infused bilaterally into
the BLA (Fig. 2A), the vmPFC (Fig. 2B), or the CA1 (Fig. 2C)
10 min before the retention test of rats given a-FMHis 24 h
before or after IA training. The retention test was carried out
48 h after IA training. Controls received equivalent infusions of
saline. Latencies of all groups during IA training did not differ.
One-way ANOVA performed at the retention test revealed a
significant difference across groups (BLA: F2,24 = 58.76; P <
0.0001; vmPFC: F2,40 = 41.05; P < 0.0001; CA1: F2,27 = 34.11;
P < 0.0001). Additional analysis with Bonferroni’s MCT showed
that rats treated with a-FMHis before training and histamine in
the BLA (Fig. 2A), the vmPFC (Fig. 2B), or the CA1 (Fig. 2C)
displayed latencies significantly shorter than respective controls.
Also, latencies of rats infused with a-FMHis 24 h after training and
histamine into the BLA (Fig. 2A) or the vmPFC (Fig. 2B) were
significantly shorter than those of corresponding controls. Con-
versely, latencies of rats treated with a-FMHis intra-LV 24 h after
training and intra-CA1 histamine did not differ from their controls
(Fig. 2C). Taken together, these results indicate that histamine
never rescued IA-LTM of rats given a-FMHis before training.
When infused into the BLA or the vmPFC of animals treated with
a-FMHis after training, histamine did not restore IA-LTM. Con-
versely, it antagonized amnesia when given into the CA1 region.
These findings suggest that animals treated with a-FMHis after IA
training formed a memory of this experience and support a crucial
role for histamine neurotransmission in the CA1 during retrieval.
Intra-CA1 Infusion of Histamine Did Not Reverse Amnesia of IA-LTM
Elicited by Intra-CA1 Administration of Anisomycin. To verify
whether the amnesia induced by a-FMHis given 24 h before IA
training shared features with the memory impairment of rats
unable to consolidate memory, we investigated IA-LTM in ani-
mals that received bilateral infusion of anisomycin (80 μg/μL), a
protein synthesis inhibitor, in the CA1 immediately after train-
ing, saline or a-FMHis intra-LV 24 h after training, and saline or
histamine (1 μg/μL) into the CA1 10 min before the retention
test (Fig. 2D). Controls received comparable infusions of saline.
Latencies of all groups during the IA training did not differ.
One-way ANOVA performed on the retention test revealed a
significant group effect (F3,55 = 98.10; P < 0.0001). As shown in
Fig. 2D, Bonferroni’s MCT analysis showed no difference among
the three groups of rats given anisomycin independently of the
subsequent treatments, but all displayed latencies significantly
shorter than controls. Thus, anisomycin-treated rats showed a
substantial memory impairment that was not reversed by hista-
mine administration in the CA1.
Histamine H1 Receptor Activation Is Required for IA-LTM Retrieval.
Histaminergic fibers innervate the hippocampus through the for-
nix and a caudal route (24), and histamine modulates hippocam-
pal functions, including memory processes, through interactions
Fig. 1. Effect of histamine acute depletion through a-FMHis administration
on IA task. The schematic drawing shows the sequence of behavior proce-
dures and treatments. Rats were implanted with an infusion cannula in the
LV and distributed to three groups: one group received saline (SAL) 24 h
before and after IA training (control), a second group received a-FMHis 24 h
before IA training and SAL 24 h after training, and the third group received
SAL 24 h before IA training and a-FMHis 24 h after training. Data are
expressed as means ± SEMs of 10–12 animals for each group. ****P < 0.0001
vs. control (one-way ANOVA and Bonferroni’s MCT).
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with H1 and H2 receptors (25–27). To characterize the histamine
receptor type involved in the reversal of a-FMHis–induced am-
nesia (Fig. 2C), rats were infused with a-FMHis into the LV 24 h
after IA training and 2-(2-pyridyl)ethylamine (PEA; 1.2 μg/μL) or
dimaprit (DIM; 2.3 μg/μL) into the CA1 10 min before the re-
tention test (Fig. 3A). PEA selectively activates H1 receptors,
whereas DIM is an H2 agonist with no H1 activity (28). Controls
received equivalent infusions of saline. One-way ANOVA per-
formed at the retention test displayed a significant difference in
latency across groups (F2,42 = 118.1; P < 0.0001), and Bonferroni’s
MCT analysis indicated that rats infused with DIM had signifi-
cantly shorter latencies than those infused with saline or PEA.
Hence, DIM did not reverse a-FMHis–induced amnesia. Controls
and PEA-treated rats displayed similar levels of latency during the
retention test, thus suggesting that the H1 receptor contributed to
the full reinstatement of IA-LTM expression in animals rendered
amnesic by a-FMHis. To further investigate the role of H1 re-
ceptors, we examined the effects of pyrilamine (20 μg/μL), an H1
antagonist (29) infused in the CA1 10 min before the retention
test. During IA training, there were no significant differences
among the groups in their latencies (Fig. 3B). However, on the re-
tention test, rats infused with pyrilamine displayed shorter latencies
than those infused with saline (unpaired t test; P < 0.05) (Fig. 3B),
thus indicating that blockade of H1 receptors in the CA1 impaired
IA-LTM expression. This finding extends the observations with
PEA, strongly suggesting an active involvement of endogenous his-
tamine in IA-LTM retrieval.
Effect of Histamine Depletion on c-Fos Expression After IA-LTM Retrieval
in Rat BLA, vmPFC, and CA1. In an attempt to clarify how brain his-
tamine deficit may influence IA-LTM retrieval, we measured c-Fos
protein expression in three brain regions of rats given saline or
a-FMHis into the LV 24 h after IA training and subjected to a
retention test 48 h after training. Rats were euthanized 90 min
after the retention test. No differences in c-Fos expression were
found in the BLA or the vmPFC of rats treated with either saline
or a-FMHis (Fig. 4 A and B). Conversely, neurons immuno-
positive for c-Fos were significantly fewer in the CA1 of a-FMHis–
treated rats compared with in the control group (unpaired t test;
P < 0.0001) (Fig. 4C).
Effect of Histamine Depletion on Levels of pCREB After IA-LTM
Retrieval in Rat BLA, vmPFC, and CA1. CREB is a crucial media-
tor in the formation of IA-LTM (17, 30), and an increase in
Fig. 2. Effect of histamine infusion into the BLA, vmPFC, or CA1 on a-FMHis– or anisomycin-induced amnesia. The schematic drawings show the sequence of
behavior procedures and treatments. Rats were implanted with infusion cannula in the LV to administer a-FMHis or saline (SAL) and a second cannula bi-
laterally in the (A) BLA, (B) vmPFC, or (C and D) CA1. Data are expressed as means ± SEMs of 10–12 animals for each group. ****P < 0.0001 vs. respective
controls (one-way ANOVA and Bonferroni’s MCT). ANI, anisomycin; HA, histamine.
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CREB phosphorylation at Ser-133 in the hippocampus is spe-
cifically associated with the consolidation of IA memory (31, 32).
To investigate the influences of histamine depletion on phos-
phorylated cAMP-responsive element binding protein (pCREB)
after IA-LTM retrieval, rats were euthanized immediately after
the retention test, and pCREB levels were assessed in the BLA,
vmPFC, and CA1 of rats given saline or a-FMHis infusions in the
LV 24 h after IA training (Fig. 5). No difference of pCREB
density was found in the BLA or the vmPFC of rats given saline
or a-FMHis. Conversely, a significant decrease of pCREB was
detected in the CA1 of rats treated with a-FMHis compared with
saline-treated animals (one-way ANOVA and Bonferroni’s MCT;
F5,31 = 5.199; P < 0.001).
Discussion
This study shows that intact histamine neurotransmission is re-
quired to enable not only IA consolidation but also, retrieval.
Furthermore, it shows that H1 receptor activation in the CA1 is
necessary for IA-LTM retrieval. This finding adds strong support
to the view that retrieval is a dynamic process that requires
neuromodulatory signaling, just like acquisition, consolidation,
reconsolidation, and memory maintenance (6, 33, 34), and
identifies a crucial role for the neurotransmitter histamine in this
process. Indeed, rats temporarily depleted of histamine through
infusion of a-FMHis, an irreversible inhibitor of histidine
decarboxylase, into the LV 24 h either before or after IA training
displayed amnesia of IA training 48 h posttraining. We reported
earlier that pretraining administration of a-FMHis disrupted the
consolidation of IA memory, while leaving IA short-term mem-
ory intact (17), and suppressed brain histamine release for ∼48 h
(17). Because molecular changes specific for IA-LTM in rat
hippocampus begin immediately after the training session and
progress for less than 20 h (35, 36), the amnesia resulting from
a-FMHis infusion 24 h posttraining is likely caused by an im-
pairment of retrieval rather than consolidation. This view is
supported by the observation that intra-CA1 infusion of aniso-
mycin 12 h after training failed to disrupt IA-LTM tested 2 d
posttraining (35, 37). Indeed, the requirement of de novo protein
synthesis to consolidate IA memory is crucial only during the
immediate phase after training (35, 37). Delayed processes, such
as gene expression-dependent phases, are necessary specifically
for long-term maintenance of the memory but not for its for-
mation (36, 38).
We found that intra-CA1 injections of histamine 10 min be-
fore retrieval (therefore 48 h after training) restored IA-LTM in
rats given a-FMHis after training but failed to rescue memory
loss of animals given a-FMHis before training. In keeping with
these results, we reported earlier that application of exogenous
histamine in the CA1 of rats depleted of brain histamine pre-
training (hence, amnesic) restored IA-LTM only when given
within 6 h after training (17). A plausible interpretation of the
results presented here is that histamine injections reestablished
retrieval mechanisms impaired by its depletion but only in rats
that received a-FMHis posttraining and thus, had formed a
memory trace. This explanation fits well with the finding that
intra-CA1 infusion of exogenous histamine 10 min before the
retention test did not reverse the amnesia induced by anisomycin
injected into the CA1 immediately after training at a dose that
blocked protein synthesis for about 6 h (39). De novo protein
synthesis in the hippocampus at training is critical for the con-
solidation of IA memory (8, 35, 40), and local infusion of ani-
somycin around that time thwarts memory trace formation (35,
41). Recently, it has been reported that anisomycin also impaired
memory retrieval when administered 10 min before the retention
test (10). In this study, anisomycin is no longer active during
testing, thus ruling out the possibility that memory loss was
caused by retrieval inhibition.
The observation that exogenous histamine restored memory in
histamine-depleted rats only when given into the CA1, whereas
its administration into the BLA or the vmPFC was ineffective, is
intriguing, because the IA task can be learned when the hippo-
campus is inactivated (42, 43). We recently showed that IA-LTM
normally involves the hippocampus but can be mediated by other
structures if this region is compromised (17). Activation of the
glutamate AMPA receptor simultaneously in the hippocampus,
amygdala, entorhinal cortex, and parietal cortex is a requirement for
IA retrieval 1 d after training (33). This simultaneous activation is
not the case of histamine receptors, with operational presence in the
CA1 that is sufficient to complete retrieval, at least for the timeframe
Fig. 3. Effect of histamine receptor ligands infusion into CA1 on a-FMHis–
induced amnesia. The schematic drawings show the sequence of procedures
and treatments. Rats were implanted with infusion cannulas in the (A) LV
and (B) CA1 bilaterally. Data are expressed as means ± SEMs of 8–12 animals
for each group. PYR, pyrilamine; SAL, saline. *P < 0.05 vs. controls (unpaired
t test); ***P < 0.001 vs. controls (one-way ANOVA and Bonferroni’s MCT).
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investigated in this study. There is much evidence that activation of
H2 receptors potentiates consolidation in aversive tasks (14, 27, 44),
including IA (26, 45). The hippocampus expresses H1 and H2 re-
ceptors (46, 47), and both facilitate cAMP accumulation (48). Hip-
pocampal infusion with the H2 receptor agonist DIM 10 min before
the retention test failed to restore a-FMHis–induced amnesia,
whereas rats injected with the H1 receptor agonist PEA showed la-
tencies similar to those of saline-injected controls. Furthermore,
administering the H1 antagonist pyrilamine 10 min before retention
test in rats with normal levels of histamine completely disrupted IA
retention. This result strongly supports the notion that histamine
signaling through H1 receptors is essential for IA-LTM retrieval. Our
results are in agreement with previous reports showing that the H1
receptor is implicated in memory processes, because H1 receptor
KO mice showed impaired memory performance in the Barnes
maze (49) and the radial maze task (50). Accordingly, long-term
potentiation in the CA1 was significantly reduced in H1-KO com-
pared with WT mice (49). Studies using c-fos-tTA reporter mice
have shown that the same neurons in the amygdala, hippocampus,
and cortex that are active during contextual fear learning are reac-
tivated when memory is retrieved (51, 52). Recently, it has been
reported that CA1 neurons that were engaged during contextual fear
learning reduced levels of pCREB and were responsible for re-
instating memory representations that occurred during learning in
the cortex at the time of retrieval (53). When those specific CA1
neurons were silenced, specific cortical reactivation was reduced, and
mice became unable to retrieve a previously formed contextual fear
memory (53). We may speculate that IA-LTM shares these features
with contextual fear memory and that H1 receptor activation is
necessary for reactivating the CA1 neurons engaged during learning,
thus being responsible for reinstatement of cortical-specific activity
necessary for retrieval. Consistent with this idea, given that gene
expression in c-fos-tTA mice largely recapitulated endogenous c-Fos
expression (52), we found that, 90 min after exposure to the re-
tention test, c-Fos–positive neurons were significantly fewer in the
CA1 of a-FMHis–treated rats that also displayed amnesia com-
pared with those in the same region of animals given saline and
displaying intact IA-LTM retention. Previous studies supported
this contention (53, 54). Immediately after the retention test, we
found reduced levels of pCREB in the CA1 of a-FMHis–treated
animals compared with in controls. CREB phosphorylation
represents a crucial step for the consolidation of LTM (30), and
increases in pCREB levels associated with retrieval of fear
conditioning as well as spatial memory in different brain regions,
A
B
C
Fig. 4. c-Fos expression in the CA1 of rats trained and tested for IA memory is blunted in a-FMHis–treated rats. The schematic drawing shows the sequence of
procedures and treatment. Brain coronal sections show the effect of exposure to retention test on c-Fos protein expression in the (A) BLA, (B) vmPFC, and
(C) CA1 of rats given intra-LV infusions of saline (SAL) or a-FMHis 24 h after IA training. Data are expressed as means ± SEM of three to four rats for each
group. (Scale bars: A, 100 μm; B, 500 μm; C, Upper, 100 μm; C, Lower, 500 μm.) ****P < 0.0001 (unpaired t test).
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including the hippocampus, have been reported (55, 56). We
suggest that increased levels of pCREB are required for the
retrieval of IA-LTM through activation of H1 receptors. Con-
sistently, earlier reports indicate that histamine signaling is
necessary to trigger CREB phosphorylation in the hippocampus
(17, 57). The hippocampus is involved in both the aversive
component of the IA and its contextual aspect as reviewed in the
work by Izquierdo et al. (58).
Taken together, this study suggests (i) that the integrity of the
histaminergic system in the CA1 region of the hippocampus is
crucial for IA-LTM retrieval, (ii) that histamine-depleted rats do
not retrieve IA-LTM and display a reduced number of c-Fos–
positive cells as well as a lower level of pCREB in CA1 after
retrieval compared with controls, and (iii) that blockade of H1
receptors in the CA1 of normal rats impairs the retrieval of IA-
LTM 2 d after training. Advances in the understanding of
mechanisms underlying IA memory may help in the search for
treatments of psychiatric diseases, such as posttraumatic stress
disorder or obsessive–compulsive disorder. Here, we provide
evidence that targeting the histaminergic system may modify the
encoding, consolidation, and retrieval of emotional memory.
Materials and Methods
Animals. Male Wistar rats (3 mo old; 300–330 g) purchased from Centro de
Modelos Biologicos Experimentais of the Pontifical Catholic University of Rio
Grande do Sul (our regular provider) were used. Animals were housed four
to a cage with water and food ad libitum under a 12-h light/dark cycle (lights
on at 7:00 AM). The temperature of the animals’ room was maintained at
23 °C ± 1 °C. All procedures were in accordance with the NIH’s Guide for the
Care and Use of Laboratory Animals (59) and approved by Animal Com-
mittee on Ethics in the Care and Use of Laboratory Animals of the Pontifical
Catholic University of Rio Grande do Sul.
Surgery.At least 1wk after their arrival, animals were anesthetized (75mg/kg
ketamine plus 10 mg/kg xylazine i.p.) and placed on a stereotaxic frame
(Kopf). A stainless steel cannula (22 gauge) was implanted in the LV (anterior,
−0.9 mm; lateral, −1.5 mm; ventral, −2.6 mm from Bregma) (60) and fixed to
the skull by using dental cement. Animals were also implanted bilaterally
with 22-gauge guide cannulas 1 mm above the CA1 region of the dorsal
hippocampus (anterior, −4.2 mm; lateral, ±3.0 mm; ventral, −1.8 mm from
Bregma), the BLA (anterior, −2.4 mm; lateral, ±5.1 mm; ventral, −7.5 mm
from Bregma), or the vmPFC (anterior, +3.2 mm; lateral, ±0.8 mm; ventral,
−2.0 mm from Bregma) (60). Cannula placements were verified postmortem
as described in detail in SI Materials and Methods. Animals were allowed 7 d
to recover from surgery before behavioral procedures. All rats were handled
once daily for 3 consecutive d, and all behavioral procedures was conducted
between 8:00 and 11:00 AM.
IA Task. The apparatus consisted of a Plexiglas box (50 × 25 × 25 cm) with a
floor made of parallel 1-mm-caliber bronze bars spaced 0.8 cm apart and a
wood platform (5-cm high, 8-cm wide, and 25-cm long) on the left extreme
of the box. For the IA training session, animals were gently placed on the
platform facing the left rear corner. When stepping down and placing their
four paws on the grid, animals received a 2-s 0.5-mA scrambled foot shock
and then, were immediately withdrawn from the training box. After 48 h,
animals were placed again on the platform as described for a retention test
without the foot shock. In the retention test, the stepdown latency was
300 s. Latency to stepdown was measured with an automated stopwatch.
Drugs and Infusion Procedures. At the time of drug microinfusions, animals
were gently restrained by hand, and an injection needle (30 gauge) was fitted
tightly into the guide, extending 1 mm from the tip of the guide cannulas.
The injection needle was connected to a 10-μL Hamilton microsyringe, and
the infusions were performed at a rate of 0.5 μL/30 s. The injection needle
was left in place for an additional 60 s to minimize backflow. It was then
carefully withdrawn and placed on the other side, where the procedure was
repeated. Infusions into the BLA, vmPFC, or CA1 were performed 10 min
before the retention test. Infusions into the LV were performed 24 h either
before or after IA training. The drugs used were histamine (1 μg/μL), DIM
(2.3 μg/μL), PEA (1.2 μg/μL), pyrilamine (20 μg/μL), and anisomycin (80 μg/μL)
purchased from Sigma-Aldrich. The a-FMHis (5 μg/μL) was synthesized at
Abbott Laboratories. The doses were chosen among those found to be ef-
fective in previous papers and had no effects on locomotion or exploration
activity (26, 61). The volume of the drugs infused was 0.5 μL per side in the
BLA and 1 μL per side into the CA1, vmPFC, and LV. Control groups received
equal volumes of sterile saline (0.9%).
Immunohistochemistry. Ninety minutes after the retention test, animals were
deeply anesthetized with chloral hydrate (400 mg/kg i.p.) and perfused
transcardially with saline followed by 4% (vol/vol) paraformaldehyde in 0.1M
phosphate buffer (pH 7.4). Brains were postfixed in the same solution
overnight (4 °C) and cryoprotected in 30% (wt/vol) sucrose in phosphate
buffer. Forty-micrometer-thick sections were then processed for standard
immunostaining (details in SI Materials and Methods).
Western Blotting Analysis. Animals were killed immediately after the IA re-
tention test, the brain was dissected out on ice, and the amygdala, the vmPFC,
and the CA1 were immediately isolated. The pooled structures (left and right)
were individually homogenized in 200 μL ice-cold lysis buffer containing
protease and phosphatase inhibitors [50 mM Tris·HCl (pH 7.5), 50 mM NaCl,
10 mM EGTA, 5 mM EDTA, 2 mM sodium pyrophosphate, 4 mM p-nitro-
phenyl phosphate, 1 mM Na3VO4, 1.1 mM PMSF, 20 μg/μL leupeptin, 50 μg/μL
aprotinin, 0.1% SDS] and centrifuged at 13.8 × g at 4 °C for 15 min. The
following procedure is described in detail in SI Materials and Methods. For
each sample, a ratio of pSer133-CREB/CREB densities was calculated, and then,
all of the individual rates were expressed as a percentage of the average of
ratios obtained from the control group.
Data and Statistical Analysis. Statistical analysis was performed by using Prism
Software (GraphPad). Data are expressed as means ± SEMs. IA latencies and
number of c-Fos–positive nuclei as well as the pCREB/CREB ratio were ana-
lyzed with unpaired t test or one-way ANOVA. The source of the detected
significances was determined by Bonferroni’s multiple comparison posthoc
test. P values less than 0.05 were considered statistically significant. The
number of rats per group is indicated in the figures.
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Fig. 5. Effect of histamine depletion on levels of CREB phosphorylation in
the BLA, vmPFC, and CA1 of rats trained and tested for IA memory. The
schematic drawing displays the sequence of procedures and treatments. Rats
were implanted with an infusion cannula in the LV. Representative immu-
noblots and densitometric quantification are shown. Data are expressed as
means ± SEMs of four rats. **P < 0.01 vs. respective saline (SAL; one-way
ANOVA and Bonferroni’s MCT).
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SI Materials and Methods
Correct Cannula Placements. Correct cannula placement was ver-
ified by infusing a 4% (wt/vol) methylene blue solution over 30 s
into the CA1 region of the dorsal hippocampus, the vmPFC (both
1 μL per side), or the BLA (0.5 μL per side) 2 d after the behavioral
procedures. Rats were euthanized 30 min later with an overdose of
anesthetic. Brains were removed and stored in formalin. The spread
of the dye was taken as an estimate of drug infusions in the same
animal. Cannula placements were considered correct when the
spread was 1 mm3 (62–64) or less from the intended infusion sites,
which occurred in 98% of the rats. Only behavioral data from
animals with cannulas placed correctly were analyzed.
Immunohistochemistry Procedure. Ninety minutes after IA reten-
tion test, to fully assess c-Fos expression, rats were deeply an-
esthetized with chloral hydrate (400 mg/kg i.p.) and perfused
transcardially with cold physiological saline followed by 4% (vol/vol)
paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.4).
Brains were postfixed in the same solution overnight (4 °C) and
cryoprotected in 30% (wt/vol) sucrose in PB; 40-μm-thick sec-
tions were cut on a cryostat and collected in PB. Sections were
preincubated in 0.75% H2O2 in PB for 30 min and 0.2% BSA for
30 min and then incubated overnight in rabbit c-Fos primary anti-
body (1:5,000; Sigma-Aldrich) at 4 °C. The immunoreactive product
was detected with the avidin-biotin peroxidase system (Vectastain
Kit; Vector Laboratories). After washing, sections were mounted
on gelatin-coated slides, dehydrated, coverslipped, and observed
using an Olympus BX40 Microscope equipped with a Nikon DS-F1
Camera. c-Fos–immunopositive nuclei were counted bilaterally us-
ing the ImageJ software (NIH) on four to five sections per region
per rat and normalized to a 1-mm2 area according to the work by
Provensi et al. (65). Atlas coordinates relative to Bregma (60) for
the sections analyzed were from −3.8 to −4.4 mm for hippocampal
CA1, from −2.12 to −2.75 mm for the BLA, and from 2.7 to
1.95 mm for the vmPFC. All regions analyzed receive histaminergic
fibers. Statistics were calculated on the average values from four
to five sections of individual regions for each animal.
pCREB Experiments and Western Blotting Analysis. For the experi-
ments aimed to evaluate pCREB levels, male Wistar rats were
infused with saline or a-FMHis through a cannula into the LV
24 h after the IA training session. Immediately after the IA re-
tention test, animals were killed, rat brains were dissected out on
ice, and the BLA, the CA1 region of the hippocampus, and the
vmPFC were isolated immediately. Pools of structures (left and
right) were individually homogenized in 200 μL ice-cold lysis
buffer containing protease and phosphatase inhibitors [50 mM
Tris·HCl (pH 7.5), 50 mM NaCl, 10 mM EGTA, 5 mM EDTA
2 mM sodium pyrophosphate, 4 mM p-nitrophenyl phosphate,
1 mM Na3VO4, 1.1 mM PMSF, 20 μg/μL leupeptin, 50 μg/μL
aprotinin, 0.1% SDS] and centrifuged at 13.8 × g at 4 °C for
15 min. Supernatants were collected, and levels of total protein
were quantified using Pierce BCA Protein Assay (Thermo Sci-
entific). Aliquots of protein homogenates were diluted with a
mix of lysis buffer and loading buffer two times [50 mM Tris
(pH 6.8), 100 mM DTT, 10% (vol/vol) glycerol, 1% bromo-
phenol blue, 2% (vol/vol) SDS] and boiled for 10 min. Aliquots
containing 50 μg total proteins were resolved by electrophoresis
on a 10% SDS/PAGE and transferred on PVDF membranes
(Immobilon Transfer Membranes; Millipore). Membranes were
then blocked in Tris-buffered saline (pH 7.6) containing 0.1%
Tween 20 (TBS-T) and 5% (wt/vol) nonfat dry milk (Bio-Rad
Laboratories) for 2 h at room temperature and incubated over-
night at 4 °C with mAbs against pCREB (Ser133; Cell Signaling
Technology) or CREB (Cell Signaling Technology) diluted
1:1,000 in TBS-T containing 5% (wt/vol) BSA or 5% (wt/vol)
nonfat dry milk, respectively. Immunodetection was performed
with secondary antibodies (anti-rabbit IgG conjugated to
HRP; Cell Signaling Technology) diluted 1:5,000 in TBS-T
containing 1% nonfat dry milk. Blots were washed in TBS-T,
and then, reactive bands were detected by using ECL (Luminata
Crescendo; Millipore). Quantitative densitometry was assessed
using QuantityOne software (Bio-Rad Laboratories). A ratio of
pSer133-CREB/CREB densities was calculated of all samples,
and all of the individual rates were expressed as percentages of
the average of ratios obtained from the control group.
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